QQ客服 官方微博 反馈留言

	A miRNA-based signature predicts development of disease recurrence in HER2 positive early breast cancer after adjuvant trastuzumab-based treatment.
	Du, Feng; Yuan, Peng; Wang, Jiayu; Ma, Fei; Luo, Yang; Xu, Binghe
	2016
卷号	34期号:15
ISSN号	0732-183X
DOI	10.1200/JCO.2016.34.15_suppl.e12070
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6384899
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Du, Feng,Yuan, Peng,Wang, Jiayu,et al. A miRNA-based signature predicts development of disease recurrence in HER2 positive early breast cancer after adjuvant trastuzumab-based treatment.[J],2016,34(15).
APA	Du, Feng,Yuan, Peng,Wang, Jiayu,Ma, Fei,Luo, Yang,&Xu, Binghe.(2016).A miRNA-based signature predicts development of disease recurrence in HER2 positive early breast cancer after adjuvant trastuzumab-based treatment..,34(15).
MLA	Du, Feng,et al."A miRNA-based signature predicts development of disease recurrence in HER2 positive early breast cancer after adjuvant trastuzumab-based treatment.".34.15(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。